US2021276954A1PendingUtilityA1
Concise process for preparing 3-pyrrolidine carboxylic acid derivatives
Assignee: OKINAWA INST SCIENCE & TECH SCHOOL CORPPriority: Aug 1, 2016Filed: Mar 25, 2021Published: Sep 9, 2021
Est. expiryAug 1, 2036(~10 yrs left)· nominal 20-yr term from priority
C07D 207/16C07C 201/12C07D 209/54C07C 205/51
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a process for preparing 3-pyrrolidine carboxylic acid derivatives, and particularly a simple process for preparing 5-substituted 3-pyrrolidine carboxylic acid derivatives. In addition, the present invention relates to a novel pyrrolidine carboxylic acid derivative, its manufacture, pharmaceutical compositions containing it and its use as a catalyst.
Claims
exact text as granted — not AI-modified1 . A process for preparing compound of formula IV:
wherein
R 1 and R 2 are each independently hydrogen, C 1-7 -alkyl, C 3-7 -cycloalkyl, halo-C 1-7 -alkyl, C 1-7 -alkoxy-C 1-7 -alkyl, aryl-C 1-7 -alkyl, or heteroaryl-C 1-7 -alkyl; or
R 1 and R 2 together form —(CH 2 ) n —, and n is 2 to 6;
R 3 is hydrogen, C 1-7 -alkyl, C 3-7 -cycloalkyl, halo-C 1-7 -alkyl, C 1-7 -alkoxy-C 1-7 -alkyl, aryl-C 1-7 -alkyl, or heteroaryl-C 1-7 -alkyl;
R 4 is hydrogen, C 1-7 -alkyl, C 3-7 -cycloalkyl, halo-C 1-7 -alkyl, C 1-7 -alkoxy-C 1-7 -alkyl, aryl-C 1-7 -alkyl, or heteroaryl-C 1-7 -alkyl; and
R 5 is hydrogen, C 1-7 -alkyl, C 3-7 -cycloalkyl, halo-C 1-7 -alkyl, C 1-7 -alkoxy-C 1-7 -alkyl, aryl-C 1-7 -alkyl, or heteroaryl-C 1-7 -alkyl;
or a pharmaceutically acceptable salt thereof, which process comprises
step A: reacting compound of formula II:
wherein R 1 and R 2 are as defined above, with compound of formula III:
wherein R 3 , R 4 and R 5 are as defined above, in the presence of at least one of compound X which is selected from the group consisting of:
to obtain compound of formula IV.
2 . The process according to claim 1 for preparing compound of formula IV:
wherein
R 1 and R 2 are each independently hydrogen, C 1-7 -alkyl, or halo-C 1-7 -alkyl-; or
R 1 and R 2 together form —(CH 2 ) n —, and n is 2 to 5;
R 3 is hydrogen, C 1-7 -alkyl, or halo-C 1-7 -alkyl;
R 4 is hydrogen, C 1-7 -alkyl, halo-C 1-7 -alkyl, or aryl-C 1-7 -alkyl; and
R 5 is hydrogen, C 1-7 -alkyl, or halo-C 1-7 -alkyl;
or a pharmaceutically acceptable salt thereof, which process comprises
step A: reacting compound of formula II:
wherein R 1 and R 2 are as defined above, with compound of formula III:
wherein R 3 , R 4 and R 5 are as defined above, in the presence of at least one of compound X which is selected from the group of B, D, E, F, and F′
to obtain compound of formula IV.
3 . The process according to claim 1 for preparing compound of formula IV:
wherein
R 1 and R 2 are each independently hydrogen or C 1-7 -alkyl; or
R 1 and R 2 together form —(CH 2 ) n —, and n is 4 or 5;
R 3 is hydrogen or C 1-7 -alkyl;
R 4 is hydrogen, C 1-7 -alkyl, or benzyl; and
R 5 is hydrogen or C 1-7 -alkyl;
or a pharmaceutically acceptable salt thereof, which process comprises
step A: reacting compound of formula II:
wherein R 1 and R 2 are as defined above, with compound of formula III:
wherein R 3 , R 4 and R 5 are as defined above, in the presence of at least one of compound X which is selected from the group of F and F′
to obtain compound of formula IV.
4 . The process according to claim 1 , which process further comprises
reacting the compound of formula II with the compound of formula III, in the presence of an additive.
5 . The process according to claim 4 , wherein
the additive is at least one selected from the group consisting of acetic acid, benzoic acid, and imidazole.
6 - 12 . (canceled)Join the waitlist — get patent alerts
Track US2021276954A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.